COA verifiedAppetite, glucose, body fat
Tirzepatide
Dual GIP/GLP-1 agonist studied for substantial appetite reduction, glucose control and weight loss.
10 mg
$249

Investigational GLP-1/GIP/glucagon triple agonist studied in obesity and metabolic disease.
Presentation
10 mg
Price
$329